Scientists track 'Genetic time Bomb' to unlock secrets of deadly lung disease
NCT ID NCT05584722
Summary
This study aims to understand why some people with a genetic risk for a severe lung disease called pulmonary arterial hypertension (PAH) develop the condition while others remain healthy. Researchers will track 150 participants, including patients, healthy people with the genetic risk, and healthy controls, over four years with regular check-ups and blood tests. The goal is to find biological clues that predict who gets sick, which could lead to better monitoring and future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.